Serum IL-18 Levels are not Increased in Patients with Untreated Graves' Ophthalmopathy

Hormone and Metabolic Research

Volumn 36, Issue 1, 2004, Pages 44-47

  Wakelkamp, I M M J ^a,b   Prummel, M F ^a   Wiersinga, W M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmune thyroid diseases; ELISA; Graves' ophthalmopathy; Serum IL 18

Indexed keywords

ANTITHYROID AGENT; INTERLEUKIN 8;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING HABIT; THYROID FUNCTION;

ADULT; ANTITHYROID AGENTS; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAVES DISEASE; HUMANS; INTERLEUKIN-18; MALE; MIDDLE AGED; RECEPTORS, THYROTROPIN; SMOKING;

EID: 1442265820     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-814102     Document Type: Article

References (20)

1. McInnes IB, Gracie JA, Leung BP, Wie XQ, Liew FY. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunology Today 2000; 21: 312-315
2. Lebel-Binay S, Berger A, Zinzindohoue F, Cugnenc P, Thiounn N, Fridman WH, Pages F. Interleukin-18: biological properties and clinical implications. European Cytokine Network 2000; 11: 15-26
3. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, Kennedy K, Carter R, Wie XQ, Xu D, Field M, Foulis A, Liew FY, Mclnnes IB. A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 1999; 104: 1393-1401
4. Tanaka KF, Shintani F, Fujii Y, Yagi G, Asai M. Serum interleukin-18 levels are elevated in schizophrenia. Psychiatry Res 2000; 96: 75-80
5. Urushihara N, Iwagaki H, Yagi T, Kohka H, Kobashi K, Morimoto Y, Yoshino T, Tanimoto T, Kurimoto M, Tanaka N. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia. J Pediatr Surg 2000; 35: 446-449
6. Losy J, Niezgoda A. IL-18 in patients with multiple sclerosis. Acta Neurol Scand 2001; 104: 171-173
7. Miyauchi S, Matsuura B, Onji M. Increased levels of serum interleukin-18 in Graves'disease. Thyroid 2000; 10: 815-819
8. Prummel MF, Wiersinga WM, Van der Gaag R, Mourits MP, Koornneef L Soluble IL-2 receptor levels in patients with Graves' ophthalmopathy. Clinical & Experimental Immunology 1992; 88: 405-409
9. Salvi M, Girasole G, Pedrazzoni M, Passen M, Giuliani N, Minelli R, Braverman LE, Roti E. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease. Journal of Clinical Endocrinology & Metabolism 1996; 81: 2976-2979
10. Hofbauer LC, Muhlberg T, Konig A, Heufelder G, Schworm HD, Heufelder AE. Soluble Interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves ophthalmopathy undergoing orbital radiotherapy. Journal of Clinical Endocrinology & Metabolism 1997; 82: 2244-2247
11. Mysliwiec J, Kretowski A, Topolska J, Siewko K, Jakubczyk D, Szelachowska M, Mikita A, Kinalska I. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids. Horm Metab Res 2001; 33: 739-743
12. Wakelkamp IMMJ, Gerding MN, van der Meer JW, Prummel MF, Wiersinga WM. Both Th1- and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy. Clinical & Experimental Immunology 2000; 121: 453-457
13. Prummel MF, Mounts MP, Berghout A, Krenning EP, van der Gaag R, Koornneef L, Wiersinga WM. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy. New England Journal of Medicine 1989; 321: 1353-1359
14. Mounts MP, Koornneef L, Wiersinga WM, Prummel MF, Berghout A, van der Gaag R. Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. British Journal of Ophthalmology 1989; 73: 639-644
15. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocrine Reviews 2000; 21: 168-199
16. Wakelkamp IMMJ, Bakker O, Baldeschi L, Wiersinga WM, Prummel MF. TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients. Clin Endocrinol (Oxf) 2003; 58: 280-287
17. Wakelkamp IMMJ, Gerding MN, van der Meer JWC, Prummel MF, Wiersinga WM. Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy. Clinical & Experimental Immunology 2002; 127: 316-320
18. Prummel MF, Wiersinga WM. Smoking and risk of Graves' disease. JAMA 1993; 269: 479-482
19. Tellez M, Cooper J, Edmonds C. Graves' ophthalmopathy in relation to cigarette smoking and ethnic origin. Clinical Endocrinology 1992; 36: 291-294
20. Shine B, Fells P, Edwards OM, Weetman AP. Association between Graves'ophthalmopathy and smoking. Lancet 1990; 335: 1261-1263